Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Latest Information Update: 26 Sep 2024
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Acronyms SEPVADIS
- 21 Sep 2021 Status changed from not yet recruiting to recruiting.
- 24 Aug 2021 Planned initiation date changed from 1 Mar 2021 to 1 Sep 2021.
- 23 Mar 2021 New trial record